A Kaplan-Meier survival analysis was carried out to determine the relationship between the expression of BUB1B, TTK, and BUB3 and the overall survival and recurrence-free survival of ovarian cancer patients treated with paclitaxel. The gene discussed is BUB3; the disease is ovarian carcinoma.